EMA fast-tracks enzyme replacement therapy for lysosomal acid lipase deficiency

View source ↗

Summary

EU regulators have fast-tracked an enzyme replacement therapy for lysosomal acid lipase deficiency, accelerating development and potential access.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lysosomal Acid Lipase Deficiency